KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) EBT Margin (2016 - 2025)

Idexx Laboratories has reported EBT Margin over the past 17 years, most recently at 28.15% for Q4 2025.

  • Quarterly results put EBT Margin at 28.15% for Q4 2025, up 128.0% from a year ago — trailing twelve months through Dec 2025 was 30.77% (up 229.0% YoY), and the annual figure for FY2025 was 30.77%, up 229.0%.
  • EBT Margin for Q4 2025 was 28.15% at Idexx Laboratories, down from 31.19% in the prior quarter.
  • Over the last five years, EBT Margin for IDXX hit a ceiling of 32.66% in Q2 2025 and a floor of 19.88% in Q2 2022.
  • Median EBT Margin over the past 5 years was 29.06% (2022), compared with a mean of 28.38%.
  • Biggest five-year swings in EBT Margin: tumbled -1059bps in 2022 and later surged 1042bps in 2023.
  • Idexx Laboratories' EBT Margin stood at 23.95% in 2021, then increased by 7bps to 25.73% in 2022, then increased by 3bps to 26.58% in 2023, then increased by 1bps to 26.87% in 2024, then increased by 5bps to 28.15% in 2025.
  • The last three reported values for EBT Margin were 28.15% (Q4 2025), 31.19% (Q3 2025), and 32.66% (Q2 2025) per Business Quant data.